Endoscopy 2022; 54(S 01): S20-S21
DOI: 10.1055/s-0042-1744597
Abstracts | ESGE Days 2022
ESGE Days 2022 Oral presentations
11:00–12:00 Thursday, 28 April 2022 Club H. Optimizing bowel preparation and your service's quality

VALIDATION OF PRIORITY CRITERIA FOR RESTARTING ENDOSCOPIC ACTIVITY AFTER THE FIRST WAVE OF COVID19 PANDEMIC IN SPAIN. THE ENDOPRIOR STUDY

L. Rivero Sánchez
1   Hospital Clínic de Barcelona, Universitat de Barcelona, IDIBAPS, CIBERHerd, Gastroenterology Department, Barcelona, Spain
,
A. García-Rodríguez
2   Hospital de Viladecans, Barcelona, Spain
,
J. Castillo
1   Hospital Clínic de Barcelona, Universitat de Barcelona, IDIBAPS, CIBERHerd, Gastroenterology Department, Barcelona, Spain
,
P. Diez-Redondo
3   Hospital Universitario Río Hortega, Valladolid, Spain
,
H. Nuñez Rodriguez
3   Hospital Universitario Río Hortega, Valladolid, Spain
,
M. Ponce
4   Hospital Clínico de Valencia, Valencia, Spain
,
M. San Juan
5   Hospital Universitario Nuestra Señora de la Candelaria, Tenerife, Spain
,
A. Seoane
6   Hospital del Mar, Barcelona, Spain
,
M. Albert Carrasco
7   Hospital Universitari Dr. Josep Trueta, Girona, Spain
,
D. Zaffalon
8   Hospital de Terrassa, Terrassa, Spain
,
C. Guarner
9   Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
,
M. Murzi
9   Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
,
R. Jover
10   Hospital Universitario de Alicante, Alicante, Spain
,
L. Medina Prado
10   Hospital Universitario de Alicante, Alicante, Spain
,
K. Aspuru Rubio
11   Hospital San Jorge de Huesca, Huesca, Spain
,
B. García Zafra
2   Hospital de Viladecans, Barcelona, Spain
,
D. Joao Matias
12   Hospital Universitario de Salamanca, Salamanca, Spain
,
A. Cárdenas
1   Hospital Clínic de Barcelona, Universitat de Barcelona, IDIBAPS, CIBERHerd, Gastroenterology Department, Barcelona, Spain
,
B. Gonzalez Suarez
1   Hospital Clínic de Barcelona, Universitat de Barcelona, IDIBAPS, CIBERHerd, Gastroenterology Department, Barcelona, Spain
,
O. Sendino
1   Hospital Clínic de Barcelona, Universitat de Barcelona, IDIBAPS, CIBERHerd, Gastroenterology Department, Barcelona, Spain
,
H. Cordoba
1   Hospital Clínic de Barcelona, Universitat de Barcelona, IDIBAPS, CIBERHerd, Gastroenterology Department, Barcelona, Spain
,
A. Fernández-Simón
1   Hospital Clínic de Barcelona, Universitat de Barcelona, IDIBAPS, CIBERHerd, Gastroenterology Department, Barcelona, Spain
,
I. Araujo
1   Hospital Clínic de Barcelona, Universitat de Barcelona, IDIBAPS, CIBERHerd, Gastroenterology Department, Barcelona, Spain
,
A. Ginés
1   Hospital Clínic de Barcelona, Universitat de Barcelona, IDIBAPS, CIBERHerd, Gastroenterology Department, Barcelona, Spain
,
J. Llach
1   Hospital Clínic de Barcelona, Universitat de Barcelona, IDIBAPS, CIBERHerd, Gastroenterology Department, Barcelona, Spain
,
G. Fernández-Esparrach
1   Hospital Clínic de Barcelona, Universitat de Barcelona, IDIBAPS, CIBERHerd, Gastroenterology Department, Barcelona, Spain
,
M. Pellisé
1   Hospital Clínic de Barcelona, Universitat de Barcelona, IDIBAPS, CIBERHerd, Gastroenterology Department, Barcelona, Spain
,
F. Balaguer
1   Hospital Clínic de Barcelona, Universitat de Barcelona, IDIBAPS, CIBERHerd, Gastroenterology Department, Barcelona, Spain
› Author Affiliations
 

Aims National Spanish societies (AEG-SEED) proposed priorization criteria for restarting the endoscopic activity after the first wave of COVID19 pandemic. The aim was to evaluate the diagnostic yield of esophagogastroduodenoscopies(EGD) and colonoscopies in symptomatic patients for detecting clinically relevant lesions(CRL)

Methods Retrospective analysis of endoscopy reports from activity restart (April-May 2020) up to December 2020 of 12 centers that prospectively used AEG-SEED (symptoms&signs list) priority criteria (high=P1, medium=P2, and low=P3). CRL (defined before data collection) were those lesions that required invasive (endoscopic/surgical)treatment, hospitalization and/or close follow-up. Urgent, surveillance, therapeutic and colorectal cancer (CRC) screening procedures were excluded

Results 2058 (981 EGD; 1077 colonoscopies) in 1900 patients (56% women;58±16 years) were registered. Elapsed time (months; median[IQR]) from request to procedure completion for P1, P2 and P3 were 3 (2-5), 4 (3-7) and 6 (4-8) respectively. Overall CRL rates in EGD and colonoscopies were 11% and 18% respectively. CRL rates of EGD in P1, P2, and P3 were 13%, 14%, and 6%; and 26%, 18%, and 12% of colonoscopies. Among CRL, 6(0.6%) upper cancers (3 gastric, 2 esophageal, 1 duodenal) and 35(3.2%) CRC were detected. CRL and CRC rates in patients with positive, not-performed and negative fecal occult blood test (FOBT) were 31% and 9%, 17% and 2%, 10% and 0 respectively

Table 1

FOBT performed in a non-protocolized fashion*

Positive FOBT*n = 180 (%)

FOBT not-performed n=800 (%)

Negative FOBT*n =97 (%)

CRL

55 (31)

133 (17)

10 (10)

–CRC

16 (9)

19 (2)

0

–Advanced adenoma/serrated lesion

25 (14)

60 (8)

6 (6)

–Non-neoplastic lesions

14 (8)

42 (5)

4 (4)

Zoom Image
Fig. 1

Conclusions AEG-SEED priority criteria identified those symptomatic patients with higher-risk of having CRL in colonoscopies according to priority level, with a higher diagnostic yield according to FOBT results. Optimize priorization is especially needed for EGD to manage waiting lists in open-access endoscopy units



Publication History

Article published online:
14 April 2022

© 2022. European Society of Gastrointestinal Endoscopy. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany